about
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...
Read More
10.90
-0.09
(-0.82%)
14,801
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Polyrizon Ltd is on 22 Sep 2026 for the purpose of Polyrizon Ltd Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Polyrizon Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..